The multiple functions of HIV-1 Tat: Proliferation versus apoptosis

Frontiers in Bioscience

Volumn 11, Issue 1 P.447-888, 2006, Pages 708-717

  Peruzzi, Francesca ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

AIDS; HIV 1; Immune deficiency; Immune system; Infection; Review; Signaling Pathways; Tat; Virus

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 32944481298     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1829     Document Type: Review

References (110)

1. Global situation of the HIV/AIDS' epidemic, end 2004. Wkly Epidemiol Rec 79 (50), 441-449 (2004)
2. Report on the global AIDS epidemic 2004. UNAIDS (2004)
3. A. G. Fisher, M. B. Feinberg, S. F. Josephs, M. E. Harper, L. M. Marselle, G. Reyes, M. A. Gonda, A. Aldovini, C. Debouk, R. C. Gallo& et al: The transactivator gene of HTLV-III is essential for virus replication. Nature 320 (6060), 367-371 (1986)
4. B. R. Cullen: Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 46 (7), 973-982 (1986)
5. J. Hauber, A. Perkins, E. P. Heimer& B. R. Cullen: Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events. Proc Natl Acad Sci U S A 84 (18), 6364-6368 (1987)
6. C. Neuveut& K. T. Jeang: Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. J Virol 70 (8), 5572-5581 (1996)
7. H. K. Chang, R. C. Gallo& B. Ensoli: Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat Protein. J Biomed Sci 2(3), 189-202 (1995)
8. A. Marcello, M. Zoppe& M. Giacca: Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator. IUBMB Life 51 (3), 175-181 (2001)
9. K. T. Jeang, H. Xiao& E. A. Rich: Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem 274 (41), 28837-28840 (1999)
10. W. G. Gutheil, M. Subramanyam, G. R. Flentke, D. G. Sanford, E. Munoz, B. T. Huber& W. W. Bachovchin: Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity. Proc Natl Acad Sci U S A 91 (14), 6594-6598 (1994)
11. H. Xiao, C. Neuveut, H. L. Tiffany, M. Benkirane, E. A. Rich, P. M. Murphy& K. T. Jeang: Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A 97 (21), 11466-11471 (2000)
12. M. Tyagi, M. Rusnati, M. Presta& M. Giacca: Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 276 (5), 3254-3261 (2001)
13. Y. Liu, M. Jones, C. M. Hingtgen, G. Bu, N. Laribee, R. E. Tanzi, R. D. Moir, A. Nath& J. J. He: Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 6 (12), 1380-1387 (2000)
14. B. Fleischer: CD26: a surface protease involved in T-cell activation. Immunol Today 15 (4), 180-184 (1994)
15. A. Yaron& F. Naider: Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol 28 (1), 31-81 (1993)
16. G. Vanhoof, F. Goossens, I. De Meester, D. Hendriks& S. Scharpe: Proline motifs in peptides and their biological processing. Faseb J 9 (9), 736-744 (1995)
17. M. Subramanyam, W. G. Gutheil, W. W. Bachovchin& B. T. Huber: Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J Immunol 150 (6), 2544-2553 (1993)
18. S. Wrenger, T. Hoffmann, J. Faust, C. Mrestani-Klaus, W. Brandt, K. Neubert, M. Kraft, S. Olek, R. Frank, S. Ansorge& D. Reinhold: The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth. J Biol Chem 272 (48), 30283-30288 (1997)
19. S. Wrenger, J. Faust, C. Mrestani-Klaus, A. Fengler, A. Stockel-Maschek, S. Lorey, T. Kahne, W. Brandt, K. Neubert, S. Ansorge& D. Reinhold: Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor. J Biol Chem 275 (29), 22180-22186 (2000)
20. D. Reinhold, S. Wrenger, U. Bank, F. Buhling, T. Hoffmann, K. Neubert, M. Kraft, R. Frank& S. Ansorge: CD26 mediates the action of HIV-1 Tat protein on DNA synthesis and cytokine production in U937 cells. Immunobiology 195 (1), 119-128 (1996)
21. J. P. Moore, A. Trkola& T. Dragic: Co-receptors for HIV-1 entry. Curr Opin Immunol 9 (4), 551-562 (1997)
22. P. Secchiero, D. Zella, S. Capitani, R. C. Gallo& G. Zauli: Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells. J Immunol 162 (4), 2427-2431 (1999)
23. P. B. Tran, D. Ren, T. J. Veldhouse& R. J. Miller: Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells. J Neurosci Res 76 (1), 20-34 (2004)
24. J. Imitola, K. Raddassi, K. I. Park, F. J. Mueller, M. Nieto, Y. D. Teng, D. Frenkel, J. Li, R. L. Sidman, C. A. Walsh, E. Y. Snyder& S. J. Khoury: Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 101 (52), 18117-18122 (2004)
25. H. C. Chang, F. Samaniego, B. C. Nair, L. Buonaguro& B. Ensoli: HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. Aids 11 (12), 1421-1431 (1997)
26. G. Barillari, C. Sgadari, V. Fiorelli, F. Samaniego, S. Colombini, V. Manzari, A. Modesti, B. C. Nair, A. Cafaro, M. Sturzl& B. Ensoli: The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood 94 (2), 663-672 (1999)
27. F. Samaniego, P. D. Markham, R. C. Gallo& B. Ensoli: Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J Immunol 154 (7), 3582-3592 (1995)
28. J. Folkman, M. Klagsbrun, J. Sasse, M. Wadzinski, D. Ingber& I. Vlodavsky: A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane. Am J Pathol 130 (2), 393-400 (1988)
29. E. G. Argyris, J. Kulkosky, M. E. Meyer, Y. Xu, M. Mukhtar, R. J. Pomerantz& K. J. Williams: The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity. Virology 330 (2), 481-486 (2004)
30. A. Vendeville, F. Rayne, A. Bonhoure, N. Bettache, P. Montcourrier& B. Beaumelle: HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol Biol Cell 15 (5), 2347-2360 (2004)
31. J. P. Richard, K. Melikov, H. Brooks, P. Prevot, B. Lebleu& L. V. Chernomordik: Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem (2005)
32. G. Bu, E. A. Maksymovitch, J. M. Nerbonne& A. L. Schwartz: Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J Biol Chem 269 (28), 18521-18528 (1994)
33. D. D. Ho, A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard& M. Markowitz: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373 (6510), 123-126 (1995)
34. X. Wei, S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn& et al: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373 (6510), 117-122 (1995)
35. T. H. Finkel, G. Tudor-Williams, N. K. Banda, M. F. Cotton, T. Curiel, C. Monks, T. W. Baba, R. M. Ruprecht& A. Kupfer: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med 1 (2), 129-134 (1995)
36. M. O. Westendorp, M. Li-Weber, R. W. Frank& P. H. Krammer: Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J Virol 68 (7), 4177-4185 (1994)
37. G. Zauli, D. Gibellini, A. Caputo, A. Bassini, M. Negrini, M. Monne, M. Mazzoni& S. Capitani: The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. Blood 86 (10), 3823-3834 (1995)
38. Z. Wang, G. F. Morris, J. C. Reed, G. D. Kelly& C. B. Morris: Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein. Virology 257 (2), 502-510 (1999)
39. K. J. Sastry, M. C. Marin, P. N. Nehete, K. McConnell, A. K. el-Naggar& T. J. McDonnell: Expression of human immunodeficiency virus type I tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene 13 (3), 487-493 (1996)
40. S. C. Flores, J. C. Marecki, K. P. Harper, S. K. Bose, S. K. Nelson& J. M. McCord: Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc Natl Acad Sci U S A 90 (16), 7632-7636 (1993)
41. N. Epie, T. Ammosova, T. Sapir, Y. Voloshin, W. S. Lane, W. Turner, O. Reiner& S. Nekhai: HIV-1 Tat interacts with LIS1 protein. Retrovirology 2 (1), 6 (2005)
42. J. de Mareuil, M. Carre, P. Barbier, G. R. Campbell, S. Lancelot, S. Opi, D. Esquieu, J. D. Watkins, C. Prevot, D. Braguer, V. Peyrot& E. P. Loret: HIV-1 Tat protein enhances Microtubule polymerization. Retrovirology 2 (1), 5 (2005)
43. D. Chen, M. Wang, S. Zhou& Q. Zhou: HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. Embo J 21 (24), 6801-6810 (2002)
44. C. J. Li, D. J. Friedman, C. Wang, V. Metelev& A. B. Pardee: Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268 (5209), 429-431 (1995)
45. M. Zhang, X. Li, X. Pang, L. Ding, O. Wood, K. Clouse, I. Hewlett& A. I. Dayton: Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat. J Biomed Sci 8 (3), 290-296 (2001)
46. Y. Yang, B. Dong, P. R. Mittelstadt, H. Xiao& J. D. Ashwell: HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter. J Biol Chem 277 (22), 19482-19487 (2002)
47. M. O. Westendorp, R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K. M. Debatin& P. H. Krammer: Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375 (6531), 497-500 (1995)
48. J. C. Marecki, A. Cota-Gomez, G. M. Vaitaitis, J. R. Honda, S. Porntadavity, D. K. St Clair& S. C. Flores: HIV-1 Tat regulates the SOD2 basal promoter by altering Sp1/Sp3 binding activity. Free Radic Biol Med 37 (6), 869-880 (2004)
49. S. Nagata& P. Golstein: The Fas death factor. Science 267 (5203), 1449-1456 (1995)
50. S. R. Bartz& M. Emerman: Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. J Virol 73 (3), 1956-1963 (1999)
51. A. Ehret, M. Li-Weber, R. Frank& P. H. Krammer: The effect of HIV-1 regulatory proteins on cellular genes: derepression of the IL-2 promoter by Tat. Eur J Immunol 31 (6), 1790-1799 (2001)
52. X. Li, M. C. Multon, Y. Henin, F. Schweighoffer, C. Venot, J. LaVecchio, J. Josef, P. Stuckert, A. Mhashilkar, B. Tocque& W. A. Marasco: Upregulation of the apoptosis-associated protein Grb3-3 in HIV-1-infected human CD4(+) lymphocytes. Biochem Biophys Res Commun 276 (1), 362-370 (2000)
53. J. C. McArthur: HIV dementia: an evolving disease. J Neuroimmunol 157 (1-2), 3-10 (2004)
54. T. Fischer-Smith, S. Croul, A. E. Sverstiuk, C. Capini, D. L'Heureux, E. G. Regulier, M. W. Richardson, S. Amini, S. Morgello, K. Khalili& J. Rappaport: CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 7 (6), 528-541 (2001)
55. K. C. Williams, S. Corey, S. V. Westmoreland, D. Pauley, H. Knight, C. deBakker, X. Alvarez& A. A. Lackner: Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 193 (8), 905-915 (2001)
56. J. Torres-Munoz, P. Stockton, N. Tacoronte, B. Roberts, R. R. Maronpot& C. K. Petito: Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection. J Neuropathol Exp Neurol 60 (9), 885-892 (2001)
57. O. Bagasra, E. Lavi, L. Bobroski, K. Khalili, J. P. Pestaner, R. Tawadros& R. J. Pomerantz: Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. Aids 10 (6), 573-585 (1996)
58. G. Trillo-Pazos, A. Diamanturos, L. Rislove, T. Menza, W. Chao, P. Belem, S. Sadiq, S. Morgello, L. Sharer& D. J. Volsky: Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 13 (2), 144-154 (2003)
59. R. L. Self, P. J. Mulholland, A. Nath, B. R. Harris& M. A. Prendergast: The human immunodeficiency virus type-1 transcription factor Tat produces elevations in intracellular Ca2+ that require function of an N-methyl-D-aspartate receptor polyamine-sensitive site. Brain Res 995 (1), 39-45 (2004)
60. L. Song, A. Nath, J. D. Geiger, A. Moore& S. Hochman: Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-D-aspartate receptors at an allosteric zinc-sensitive site. J Neurovirol 9 (3), 399-403 (2003)
61. J. Rappaport, J. Joseph, S. Croul, G. Alexander, L. Del Valle, S. Amini& K. Khalili: Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukoc Biol 65 (4), 458-465 (1999)
62. M. A. Prendergast, D. T. Rogers, P. J. Mulholland, J. M. Littleton, L. H. Wilkins, Jr., R. L. Self& A. Nath: Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor. Brain Res 954 (2), 300-307 (2002)
63. N. J. Haughey, A. Nath, M. P. Mattson, J. T. Slevin& J. D. Geiger: HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem 78 (3), 457-467 (2001)
64. L. G. Epstein& H. A. Gelbard: HIV-1-induced neuronal injury in the developing brain. J Leukoc Biol 65 (4), 453-457 (1999)
65. Kruman, II, A. Nath& M. P. Mattson: HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154 (2), 276-288 (1998)
66. R. Bonavia, A. Bajetto, S. Barbero, A. Albini, D. M. Noonan& G. Schettini: HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res Commun 288 (2), 301-308 (2001)
67. S. W. Perry, J. P. Norman, A. Litzburg, D. Zhang, S. Dewhurst& H. A. Gelbard: HIV-1 Transactivator of Transcription Protein Induces Mitochondrial Hyperpolarization and Synaptic Stress Leading to Apoptosis. J Immunol 174 (7), 4333-4344 (2005)
68. K. Wong, A. Sharma, S. Awasthi, E. F. Matlock, L. Rogers, C. Van Lint, D. J. Skiest, D. K. Burns& R. Harrod: HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB. J Biol Chem 280 (10), 9390-9399 (2005)
69. V. Bergonzini, S. Delbue, J. Y. Wang, K. Reiss, M. Frisco, S. Amini, K. Khalili& F. Peruzzi: HIV-Tat promotes cellular proliferation and inhibits NGF-induced differentiation through mechanisms involving Id1 regulation. Oncogene 23 (46), 7701-7711 (2004)
70. S. Abraham, B. E. Sawaya, M. Safak, O. Batuman, K. Khalili& S. Amini: Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. Virology 309 (2), 196-202 (2003)
71. V. Beral, T. Peterman, R. Berkelman & H. Jaffe: AIDS-associated non-Hodgkin lymphoma. Lancet 337 (8745), 805-809 (1991)
72. A. M. Levine: Acquired immunodeficiency syndrome-related lymphoma. Blood 80 (1), 8-20 (1992)
73. A. S. Fauci, A. M. Macher, D. L. Longo, H. C. Lane, A. H. Rook, H. Masur& E. P. Gelmann: NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med 100 (1), 92-106 (1984)
74. R. K. Kundu, F. Sangiorgi, L. Y. Wu, P. K. Pattengale, D. R. Hinton, P. S. Gill& R. Maxson: Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma. Blood 94 (1), 275-282 (1999)
75. C. Vellutini, N. Horschowski, V. Philippon, D. Gambarelli, K. A. Nave& P. Filippi: Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene. AIDS Res Hum Retroviruses 11 (1), 21-29 (1995)
76. Y. Chang, E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles& P. S. Moore: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 (5192), 1865-1869 (1994)
77. J. Vogel, S. H. Hinrichs, R. K. Reynolds, P. A. Luciw& G. Jay: The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335 (6191), 606-611 (1988)
78. G. Barillari& B. Ensoli: Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin Microbiol Rev 15 (2), 310-326 (2002)
79. F. Ensoli, V. Fiorelli, A. Lugaresi, D. Farina, M. De Cristofaro, B. Collacchi, D. S. Muratori, E. Scala, M. Di Gioacchino, R. Paganelli& F. Aiuti: Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma. Mult Scler 8 (4), 284-288 (2002)
80. B. Ensoli, L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfield& R. C. Gallo: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67 (1), 277-287 (1993)
81. B. Ensoli, R. Gendelman, P. Markham, V. Fiorelli, S. Colombini, M. Raffeld, A. Cafaro, H. K. Chang, J. N. Brady& R. C. Gallo: Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371 (6499), 674-680 (1994)
82. H. G. Guo, S. Pati, M. Sadowska, M. Charurat& M. Reitz: Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. J Virol 78 (17), 9336-9342 (2004)
83. S. Pati, J. S. Foulke, Jr., O. Barabitskaya, J. Kim, B. C. Nair, D. Hone, J. Smart, R. A. Feldman& M. Reitz: Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat. J Virol 77 (10), 5759-5773 (2003)
84. M. C. Deregibus, V. Cantaluppi, S. Doublier, M. F. Brizzi, I. Deambrosis, A. Albini& G. Camussi: HIV-1-Tat protein activates phosphatidylinositol 3-kinase/AKT-dependent survival pathways in Kaposi's sarcoma cells. J Biol Chem 277 (28), 25195-25202 (2002)
85. D. Milani, M. Mazzoni, P. Borgatti, G. Zauli, L. Cantley& S. Capitani: Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells. J Biol Chem 271 (38), 22961-22964 (1996)
86. D. Milani, M. Mazzoni, G. Zauli, C. Mischiati, D. Gibellini, M. Giacca& S. Capitani: HIV-1 Tat induces tyrosine phosphorylation of p125FAK and its association with phosphoinositide 3-kinase in PC12 cells. Aids 12 (11), 1275-1284 (1998)
87. D. Milani, G. Zauli, L. M. Neri, M. Marchisio, M. Previati& S. Capitani: Influence of the human immunodeficiency virus type 1 Tat protein on the proliferation and differentiation of PC12 rat pheochromocytoma cells. J Gen Virol 74 (Pt 12) (2587-2594 (1993)
88. I. Shugurova, I. Bobrisheva, I. Surkova, I. Grivennikov& V. Tarantul: The expression of HIV-1 tat and nef genes induces cell-specific changes in growth properties and morphology of different types of rat cells. Cell Prolif 35 (4), 237-245 (2002)
89. R. Benezra, R. L. Davis, A. Lassar, S. Tapscott, M. Thayer, D. Lockshon& H. Weintraub: Id: a negative regulator of helix-loop-helix DNA binding proteins. Control of terminal myogenic differentiation. Ann N Y Acad Sci 599 (1-11 (1990)
90. P. Y. Desprez, E. Hara, M. J. Bissell& J. Campisi: Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Mol Cell Biol 15 (6), 3398-3404 (1995)
91. C. Q. Lin, J. Singh, K. Murata, Y. Itahana, S. Parrinello, S. H. Liang, C. E. Gillett, J. Campisi& P. Y. Desprez: A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res 60 (5), 1332-1340 (2000)
92. L. Y. Liou, C. H. Herrmann& A. P. Rice: Human immunodeficiency virus type 1 infection induces cyclin T1 expression in macrophages. J Virol 78 (15), 8114-8119 (2004)
93. M. Seeger, K. Ferrell, R. Frank& W. Dubiel: HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation. J Biol Chem 212 (13), 8145-8148 (1997)
94. G. S. Apcher, S. Heink, D. Zantopf, P. M. Kloetzel, H. P. Schmid, R. J. Mayer& E. Kruger: Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits. FEBS Lett 553 (1-2), 200-204 (2003)
95. P. G. Conaldi, A. Bottelli, A. Baj, C. Serra, L. Fiore, G. Federico, B. Bussolati& G. Camussi: Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells. Am J Pathol 161 (1), 53-61 (2002)
96. S. Ruben, A. Perkins, R. Purcell, K. Joung, R. Sia, R. Burghoff, W. A. Haseltine& C. A. Rosen: Structural and functional characterization of human immunodeficiency virus tat protein. J Virol 63 (1), 1-8 (1989)
97. M. Benkirane, R. F. Chun, H. Xiao, V. V. Ogryzko, B. H. Howard, Y. Nakatani& K. T. Jeang: Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J Biol Chem 273 (38), 24898-24905 (1998)
98. L. Deng, D. Wang, C. de la Fuente, L. Wang, H. Li, C. G. Lee, R. Donnelly, J. D. Wade, P. Lambert& F. Kashanchi: Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. Virology 289 (2), 312-326 (2001)
99. R. E. Kiernan, C. Vanhulle, L. Schiltz, E. Adam, H. Xiao, F. Maudoux, C. Calomme, A. Burny, Y. Nakatani, K. T. Jeang, M. Benkirane& C. Van Lint: HIV-1 tat transcriptional activity is regulated by acetylation. Embo J 18 (21), 6106-6118 (1999)
100. S. Pagans, A. Pedal, B. J. North, K. Kaehlcke, B. L. Marshall, A. Dorr, C. Hetzer-Egger, P. Henklein, R. Frye, M. W. McBurney, H. Hruby, M. Jung, E. Verdin& M. Ott: SIRT1 Regulates HIV Transcription via Tat Deacetylation. PLoS Biol 3 (2), e41 (2005)
101. D. K. Srivastava, C. L. Tendler, D. Milani, M. A. English, J. D. Licht& S. H. Wilson: The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme beta-polymerase. Aids 15 (4), 433-440 (2001)
102. G. Chipitsyna, D. Slonina, K. Siddiqui, F. Peruzzi, T. Skorski, K. Reiss, B. E. Sawaya, K. Khalili& S. Amini: HIV-1 Tat increases cell survival in response to cisplatin by stimulating Rad51 gene expression. Oncogene 23 (15), 2664-2671 (2004)
103. C. V. Dang& W. M. Lee: Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J Biol Chem 264 (30), 18019-18023 (1989)
104. W. A. Marasco, A. M. Szilvay, K. H. Kalland, D. G. Heiland, H. M. Reyes& R. J. Walter: Spatial association of HIV-1 tat protein and the nucleolar transport protein B23 in stably transfected Jurkat T-cells. Arch Virol 139 (1-2), 133-154 (1994)
105. Y. P. Li: Protein B23 is an important human factor for the nucleolar localization of the human immunodeficiency virus protein Tat. J Virol 71 (5), 4098-4102 (1997)
106. R. H. Stauber& G. N. Pavlakis: Intracellular trafficking and interactions of the HIV-1 Tat protein. Virology 252 (1), 126-136 (1998)
107. V. I. Romanov, A. S. Zolotukhin, N. N. Aleksandroff, P. Pinto da Silva& B. K. Felber: Posttranscriptional regulation by Rev protein of human immunodeficiency virus type 1 results in nonrandom nuclear localization of gag mRNA. Virology 228 (2), 360-370 (1997)
108. J. P. Favaro, F. Maldarelli, S. J. Arrigo& M. G. Schmidt: Effect of rev on the cytoplasmic localization of intron-containing human immunodeficiency virus type 1 RNA. Virology 255 (2), 237-249 (1999)
109. G. Zhang, M. L. Zapp, G. Yan& M. R. Green: Localization of HIV-1 RNA in mammalian nuclei. J Cell Biol 135 (1) 9-18 (1996)
110. A. Michienzi, L. Cagnon, I. Bahner& J. J. Rossi: Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA. Proc Natl Acad Sci U S A 97 (16), 8955-8960 (2000)